日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Liquid biopsy and tissue biopsy for the detection of EGFR mutations in patients with stage III non-small-cell lung cancer: an observational real-world study

液体活检和组织活检在检测III期非小细胞肺癌患者EGFR突变中的应用:一项观察性真实世界研究

Malapelle, U; Nasirova, F; Wang, A; Cooper, M; Salomonsen, R; Baser, E; Raiber-Moreau, E-A; Chuang, Y; Kim, Y J

Phase II trial, multicenter, first-line paclitaxel-avelumab treatment of inoperable angiosarcoma (KCSG UN 18-15)

II 期试验,多中心,一线紫杉醇-avelumab 治疗不可手术的血管肉瘤(KCSG UN 18-15)

Kim, H R; Kim, M; Kang, M J; Kim, J E; Kim, Y J; Park, K; Bae, W K; Lee, M-W; Hong, J-Y; Kim, Y S; Im, S-A; Lee, J; Oh, S Y

Regorafenib use in patients with unresectable hepatocellular carcinoma: analyses of subgroups of special interest in the observational REFINE study

瑞戈非尼用于不可切除肝细胞癌患者:REFINE观察性研究中特别关注亚组的分析

Kim, Y J; Merle, P; Finn, R S; Klümpen, H-J; Lim, H Y; Ikeda, M; Granito, A; Masi, G; Gerolami, R; Pinter, M; Babajanyan, S; Twumasi-Ankrah, P; Ghadessi, M; Ozgurdal, K; Qin, S

Corrigendum to "A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19-17)": [ESMO Open 9 (2024) 103668]

对“tepotinib治疗携带MET外显子14跳跃突变或扩增的晚期实体瘤患者的II期研究(KCSG AL19-17)”的更正:[ESMO Open 9 (2024) 103668]

Kang, E J; Yang, Y; Lee, S; Kim, Y J; Lim, S M; Ahn, M-J; Choi, Y J; Lee, Y; Kim, T M; Kim, I; Ahn, H K; Jeung, H-C; Lee, S I; Oh, S Y; Bae, W K; Ryu, H; Park, K H; Lee, K H

Secondary hemophagocytic lymphohistiocytosis associated with adjuvant pembrolizumab therapy in a young patient with triple-negative breast cancer: a case report with literature review

一例年轻三阴性乳腺癌患者接受帕博利珠单抗辅助治疗后继发噬血细胞性淋巴组织细胞增生症的病例报告及文献复习

Olmes, G L; Nigdelis, M P; Hamoud, B Haj; Solomayer, E-F; Bewarder, M; Bittenbring, J T; Kranzhöfer, N; Thurner, L; Kim, Y-J; Seibold, A; Doerk, M

Aristotle wires for cannulating target vessels in paediatric neuro-interventional procedures: A case-control study

用于儿科神经介入手术中目标血管插管的亚里士多德导丝:一项病例对照研究

Bhatia, K D; Blane, T; Giarola, B; Vedamuthu, J; Carraro Do Nascimento, V; Kim, Y-J; Olsson, G; Dexter, M

A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19-17)

一项针对携带 MET 外显子 14 跳跃突变或扩增的晚期实体瘤患者的 tepotinib II 期研究 (KCSG AL19-17)

Kang, E J; Yang, Y; Lee, S; Kim, Y J; Lim, S M; Ahn, M-J; Choi, Y J; Lee, Y; Kim, T M; Kim, I; Ahn, H K; Jeung, H-C; Lee, S I; Oh, S Y; Bae, W K; Ryu, H; Park, K H; Lee, K H

Factors influencing washing hands during the COVID-19 pandemic in the Ukraine population

影响乌克兰民众在新冠疫情期间洗手行为的因素

Varma, Anand; Warghane, Ashish; Dhiman, Neena K; Paserkar, Neha; Upadhye, Vijay; Modi, Anupama; Saini, Rashmi; Kim, Y J; Lee, J W; Kim, K B; Noh, J W

Evaluating a Novel Hospital-Integrated Vaccination Pathway: Enhancing Coverage among Frail Patients

评估一种新型的医院整合疫苗接种途径:提高体弱患者的疫苗接种覆盖率

Kungu, Joseph M; Namyalo, Edity; Musewa, Angella; Nitumusiima, Sarah; Keije, Phiona; Nakakooza, Catherine; Oyirwoth, Osborn; Lynch, Tom; McDowell, Cillian; Burke, Eimear; McLoughlin, Carol; O’Neill, Michelle; Spillane, Susan; Ryan, Máirín; Lee, J W; Kim, Y J; Kim, K B; Noh, J W; Di Pumpo, M; Tona, D M; Porcelli, M; Lontano, A; Regazzi, L; Pascucci, D; Bruno, S; Cadeddu, C; Laurenti, P; Pastorino, R

Inter-regional Hospital Patients’ mobility: Is co-operation better than competition?

跨区域医院患者流动:合作比竞争更好吗?

Tas, Emir; Landes, Reid D; Diaz, Eva C; Bai, Shasha; Ou, Xiawei; Buchmann, Robert; Na, Xiaoxu; Muzumdar, Radhika; Børsheim, Elisabet; Dranoff, Jonathan A; Kim, Y J; Yeob, K E; Kim, S Y; Park, J H; Guarducci, G; Moirano, F; Nante, N